Home Samsara Therapeutics

Samsara Therapeutics

In operation
Seed Round Financing
Longevity Drug Developer
Basic
Enterprise Profile

Basic Information

Samsara Therapeutics is a longevity-focused startup established in 2018. The company was co-founded by four biology professors: Frank Madeo and Didac Carmona-Gutierrez from the University of Graz in Austria, and Guido Kroemer and Oliver Kepp from Paris Descartes University. These four professors have conducted outstanding research in the fields of cellular aging, yeast aging, cancer biology, and immunogenic cell death, holding significant influence in the anti-aging domain.
Samsara Therapeutics
Hamburg,Germany
less than 15 people
January 01, 2018
info@samsaratherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Department of Preventive Healthcare
Application Scenarios
Innovative Drugs